Meanwhile, on the ambitious late 20/early 21 Vaccine Front
Some uncertainties regarding the early race leaders - the candidates from
Oxford and from a
Chinese company that use adenovirus vectors (a technology which probably can ramp up quickly to mass production levels) and the
mRNA candidate (entirely synthetic so theoretically rapidly producible but a vaccine type that has previously untested production capabilities and that is being developed by an unproven company)...
Works in progress and many other vaccine candidates are
under evaluation..
But without antibodies, whether hard-earned in cases such as Pascale's or
much more easily gained, giving an expected but uncertain level or degree of immunity, and with populations, even in hard-hit areas, having levels of potential immunity (
~4% for France)
way below what is considered needed for herd immunity (~70% the generally favored number), who knows when the disappointment over this weekend's canceled
Sponge Bob Musical can be washed away?
(apologies to anyone who might think a difficult time in the music industry being made
even more challenging is unintentionally made light of by the last remark...)